Author + information
Sable CA, Ivy DD, Beekman RH 3rd, Clayton-Jeter HD, Jenkins KJ, Mahle WT, Morrow WR, Murphy MD, Nelson RM, Rosenthal GL, Stockbridge N, Wessel DL
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil
J Am Coll Cardiol 2017;70:495–503.
1. Cover page, list of writing committee members. The footnote attached to the double-cross symbol (‡) previously read, “American Academy of Pediatrics Representative.” The footnote attached to the section symbol (§) previously read, “U.S. Food and Drug Administration Representative.” The content of the 2 footnotes has been swapped to accurately record the affiliations of the relevant committee members. Drs. Clayton-Jeter, Murphy, Nelson, and Stockbridge are now correctly recorded as representatives of the U.S. Food and Drug Administration. Drs. Jenkins, Morrow and Rosenthal are now correctly recorded as representatives of the American Academy of Pediatrics.
- 2017 American College of Cardiology Foundation